Cesario V Borlongan Selected Research

Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)

1/2022

Lovastatin Inhibits RhoA to Suppress Canonical Wnt/β-Catenin Signaling and Alternative Wnt-YAP/TAZ Signaling in Colon Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cesario V Borlongan Research Topics

Disease

45	Stroke (Strokes) 06/2023 - 01/2002
24	Inflammation (Inflammations) 12/2022 - 07/2006
17	Parkinson Disease (Parkinson's Disease) 03/2023 - 01/2002
17	Ischemic Stroke 01/2023 - 08/2004
9	Infarction (Infarctions) 01/2022 - 01/2002
8	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2023 - 06/2004
7	Central Nervous System Diseases (CNS Diseases) 03/2023 - 08/2004
7	Brain Ischemia (Cerebral Ischemia) 12/2022 - 01/2002
7	Wounds and Injuries (Trauma) 01/2012 - 07/2004
6	Nervous System Diseases (Neurological Disorders) 01/2022 - 06/2009
6	Ischemia 01/2016 - 09/2004
5	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2019 - 07/2015
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 07/2022 - 01/2018
3	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2022 - 01/2016
3	Disease Progression 01/2022 - 05/2011
3	Brain Neoplasms (Brain Tumor) 01/2022 - 01/2021
3	Neuroinflammatory Diseases 01/2021 - 01/2016
3	Epilepsy (Aura) 02/2017 - 11/2013
3	Huntington Disease (Huntington's Disease) 01/2008 - 11/2002
3	Brain Injuries (Brain Injury) 07/2006 - 01/2002
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 07/2022 - 01/2016
2	Neoplasms (Cancer) 01/2022 - 01/2017
2	Myocardial Infarction 01/2022 - 01/2016
2	Hypoxia (Hypoxemia) 01/2022 - 04/2019
2	Peripheral Nerve Injuries 12/2016 - 01/2012
2	Edema (Dropsy) 09/2014 - 08/2012
2	Seizures (Absence Seizure) 11/2013 - 11/2009
2	Alzheimer Disease (Alzheimer's Disease) 02/2009 - 03/2005
2	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2009 - 07/2004
2	Cerebral Infarction 01/2006 - 03/2005
1	Dysbiosis 09/2022
1	Pathologic Processes 07/2022
1	Hypersplenism (Anemia, Splenic) 01/2022
1	Colonic Neoplasms (Colon Cancer) 01/2022
1	Anemia 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Melanoma (Melanoma, Malignant) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021

Drug/Important Bio-Agent (IBA)

9	Neuroprotective AgentsIBA 01/2021 - 01/2002
6	Therapeutic UsesIBA 12/2022 - 11/2009
5	CytokinesIBA 09/2022 - 01/2016
5	Peptides (Polypeptides)IBA 01/2021 - 01/2005
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2022 - 01/2002
4	Oxygen (Dioxygen)IBA 01/2022 - 01/2018
4	Nerve Growth Factors (Neurotrophins)IBA 01/2008 - 06/2004
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2009
3	ST 1435IBA 01/2022 - 01/2019
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 08/2005
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2018
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2021 - 01/2019
3	Biomarkers (Surrogate Marker)IBA 12/2021 - 02/2007
3	Evans Blue (Blue, Evans)FDA Link 09/2014 - 06/2004
3	hippocampal cholinergic neurostimulating peptideIBA 01/2012 - 07/2007
3	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2006 - 01/2002
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2005 - 11/2002
2	Mevalonic Acid (Mevalonate)IBA 01/2022 - 01/2022
2	Lovastatin (Mevacor)FDA LinkGeneric 01/2022 - 01/2022
2	LipidsIBA 01/2022 - 01/2022
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2005
2	Long Noncoding RNAIBA 01/2020 - 07/2018
2	salicylhydroxamic acid (SHAM)IBA 01/2019 - 08/2016
2	Progestins (Progestagens)IBA 01/2019 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2018 - 01/2016
2	Alprostadil (Muse)FDA LinkGeneric 01/2017 - 01/2016
2	Peptide Hydrolases (Proteases)FDA Link 07/2015 - 07/2006
2	Oxidopamine (6 Hydroxydopamine)IBA 05/2011 - 01/2005
2	Quinolinic AcidIBA 01/2008 - 11/2007
2	Methylprednisolone FDA LinkGeneric 02/2005 - 08/2004
2	Immunosuppressive Agents (Immunosuppressants)IBA 02/2005 - 08/2004
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2005 - 06/2004
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2023
1	SodiumIBA 01/2023
1	Glutamic Acid (Glutamate)FDA Link 12/2022
1	SynucleinsIBA 09/2022
1	Lipoproteins (Lipoprotein)IBA 07/2022
1	ferric oxide (iron oxide)IBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	Contraceptive Agents (Contraceptives)IBA 01/2022
1	EnzymesIBA 01/2022
1	ImmunosorbentsIBA 01/2022
1	CateninsIBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	Sirtuin 3IBA 01/2022
1	superoxide dismutase 2IBA 01/2022
1	CalciumIBA 12/2021
1	Glucagon-Like Peptides (Enteroglucagon)IBA 01/2021
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021

Therapy/Procedure

37	Therapeutics 06/2023 - 07/2004
28	Transplantation 12/2022 - 01/2002
8	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2020 - 01/2009
4	Deep Brain Stimulation 01/2021 - 01/2011
4	Cell Transplantation 02/2017 - 07/2004
3	Stem Cell Transplantation 01/2021 - 01/2015
3	Injections 01/2008 - 03/2002
2	Vagus Nerve Stimulation 03/2023 - 01/2021
1	Diet Therapy (Therapy, Diet) 09/2022
1	Hematopoietic Stem Cell Transplantation 01/2022
1	Radiotherapy 01/2022
1	Drug Therapy (Chemotherapy) 01/2022
1	Catheters 10/2021